CRISPR–Cas3 genome-editing system holds therapeutic potential - Phys.org

Google News1/14/2026 – 1/16/2026

Summary

A new study has explored the therapeutic potential of the CRISPR-Cas3 genome-editing system. This system is noted for being a safer gene-editing tool and shows promise for the treatment of transthyretin amyloidosis. Additionally, the CRISPR-Cas3 system is capable of editing DNA on a much larger scale.

Share:XRedditLinkedIn

Advertisement

Lindy Score Breakdown (V4.2)

91d
Age
1
Sources
from cluster
2140
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^2140/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^2140/48 = 0.000000) reduced it below 0.5

Score BreakdownRisk 50

Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 91 days - proven survivor

Stories gain Lindy status through source reputation, network consensus, and time survival.

Breaking Similar stories

Anti-Lindy Similar stories